| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |